Vanguard Group Inc I Bio, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $160.0 $190,862 - $133 Million	829,836 Added 7.51%	11,884,917 $2.02 Million
Q2 2022 Aug 12, 2022	BUY	$0.23 - $0.46 $418,579 - $837,158	1,819,910 Added 19.71%	11,055,081 $2.92 Million
Q1 2022 May 13, 2022	SELL	$0.3 - $0.61 $401,600 - $816,588	-1,338,669 Reduced 12.66%	9,235,171 $3.96 Million
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $34,228 - $64,722	62,233 Added 0.59%	10,573,840 $5.81 Million
Q3 2021 Nov 12, 2021	BUY	$1.06 - $1.52 $65,618 - $94,094	61,904 Added 0.59%	10,511,607 $11.1 Million
Q2 2021 Aug 13, 2021	BUY	$1.22 - $1.65 $12.7 Million - $17.2 Million	10,449,703 New	10,449,703 $15.8 Million

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.8M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.